Pacira BioSciences, Inc. financial data

Symbol
PCRX on Nasdaq
Location
2000 Sierra Point Parkway, Suite 900, Brisbane, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 269 % -33.1%
Quick Ratio 54.1 % -23.4%
Debt-to-equity 95.1 % +9.93%
Return On Equity 2.8 %
Return On Assets 1.44 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43M shares -6.83%
Common Stock, Shares, Outstanding 43M shares -6.9%
Entity Public Float 930M USD -28.5%
Common Stock, Value, Issued 48K USD +2.13%
Weighted Average Number of Shares Outstanding, Basic 44M shares -4.54%
Weighted Average Number of Shares Outstanding, Diluted 44.5M shares -3.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 180M USD +6.49%
Cost of Revenue 149M USD -16.2%
Research and Development Expense 103M USD +34%
Costs and Expenses 173M USD -43.8%
Operating Income (Loss) 41.6M USD
Nonoperating Income (Expense) 3.16M USD +371%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 41.8M USD
Income Tax Expense (Benefit) 20.4M USD -43.1%
Net Income (Loss) Attributable to Parent 21.4M USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 148M USD -40%
Accounts Receivable, after Allowance for Credit Loss, Current 115M USD +14.5%
Inventory, Net 158M USD +41%
Assets, Current 563M USD -18.4%
Deferred Income Tax Assets, Net 120M USD -10.3%
Property, Plant and Equipment, Net 147M USD -11.7%
Operating Lease, Right-of-Use Asset 44.3M USD -17.8%
Intangible Assets, Net (Excluding Goodwill) 382M USD -13.1%
Goodwill 20.3M USD
Assets 1.3B USD -14.7%
Accounts Payable, Current 17.7M USD -8.68%
Employee-related Liabilities, Current 28.8M USD +32.9%
Accrued Liabilities, Current 79.6M USD +4.28%
Liabilities, Current 107M USD -65.1%
Deferred Income Tax Liabilities, Net 4.59M USD
Operating Lease, Liability, Noncurrent 38.8M USD -18.9%
Other Liabilities, Noncurrent 25.3M USD +97.9%
Liabilities 570M USD -26.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.12M USD +508%
Retained Earnings (Accumulated Deficit) -201M USD +9.64%
Stockholders' Equity Attributable to Parent 727M USD -2.98%
Liabilities and Equity 1.3B USD -14.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 35.5M USD -27.8%
Net Cash Provided by (Used in) Financing Activities -2.99M USD -6.28%
Net Cash Provided by (Used in) Investing Activities -25.6M USD -65%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 47.7M shares +1.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.84M USD -77.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 148M USD -40%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.72M USD -31.6%
Deferred Tax Assets, Valuation Allowance 24.8M USD -2.76%
Deferred Tax Assets, Gross 190M USD -10.6%
Operating Lease, Liability 48.6M USD -14.9%
Depreciation 33.6M USD +78.7%
Payments to Acquire Property, Plant, and Equipment 8.55M USD +201%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 24.9M USD
Lessee, Operating Lease, Liability, to be Paid 57M USD -17.2%
Property, Plant and Equipment, Gross 280M USD -5.57%
Operating Lease, Liability, Current 9.75M USD +6.06%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD -3.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.8M USD +0.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 1.4M USD -59.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.38M USD -28.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.2M USD -11.1%
Deferred Tax Assets, Operating Loss Carryforwards 125M USD -5.84%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 9.37M USD +39.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.1M USD +1.39%
Operating Lease, Payments 3.26M USD +1.34%
Additional Paid in Capital 1.05B USD +5.34%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 57.3M USD 0%
Depreciation, Depletion and Amortization 21.2M USD +14.9%
Deferred Tax Assets, Net of Valuation Allowance 130M USD -9.77%
Share-based Payment Arrangement, Expense 56.3M USD +9.63%
Interest Expense 14M USD -64.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%